aid: esperion-therapeutics accessModel: pricing: unknown onboarding: unknown trial: false try_now: false public: false label: Unknown confidence: low source: [] generated: '2026-07-22' method: derived image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/esperion-therapeutics.png name: Esperion Therapeutics description: >- Esperion Therapeutics, Inc. (Nasdaq: ESPR) is a commercial-stage pharmaceutical company based in Ann Arbor, Michigan, focused on discovering, developing, and commercializing innovative medicines that lower LDL cholesterol and reduce cardiovascular risk. Its lead products are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe), oral, once-daily, non-statin therapies indicated to lower elevated LDL-C in adults. As a life-sciences company, Esperion operates a corporate and scientific marketing web presence rather than a developer program; it publishes no public API, developer portal, SDKs, or technical documentation. This profile was added to the API Evangelist network as a venture-portfolio lead and enriched with verifiable company identity and domain-security signals only. url: https://raw.githubusercontent.com/api-evangelist/esperion-therapeutics/refs/heads/main/apis.yml x-type: company x-source: vc-portfolio x-backed-by: - canaan-partners x-tier: stub x-tier-reason: portfolio-lead x-api-surface: none specificationVersion: '0.20' created: '2026-07-17' modified: '2026-07-19' tags: - Company - Pharmaceutical - Biotechnology - Life Sciences - Cardiovascular - Healthcare - Therapeutics apis: [] common: - type: Website url: https://www.esperion.com/ - type: PrivacyPolicy url: https://www.esperion.com/privacy-policy - type: TermsOfService url: https://www.esperion.com/terms-use - type: Support url: https://www.esperion.com/contact-us - type: DomainSecurity url: security/esperion-therapeutics-domain-security.yml maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io x-enrichment: date: '2026-07-19' status: backfilled pass: local-v1 note: backfilled from .gitignore signal + verified work evidence